Osteoclast inhibitors in advanced prostate cancer: Does the benefit extend beyond skeletal-related events?

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)578-580
Number of pages3
JournalEuropean Urology
Volume68
Issue number4
DOIs
StatePublished - Oct 1 2015

Fingerprint

Dive into the research topics of 'Osteoclast inhibitors in advanced prostate cancer: Does the benefit extend beyond skeletal-related events?'. Together they form a unique fingerprint.

Cite this